Daily non-political popular news in brief.
Scientists solve mystery of how malaria hijacks red blood cells
01-15-2007 · EurekAlert!Northwestern University researchers have uncovered how malaria parasites break into red blood cells and how to block the invading parasites with a commonly prescribed high-blood pressure medication. This opens the door for important new drugs to which the parasites are much less likely to become resistant. Malaria is surging worldwide because of drug resistance and the lack of an effective vaccine. Jamaica, which had eradicated the disease for 50 years, recently reported an outbreak.
Read more »
Keywords: scientists, solve, mystery, malaria, hijacks, red, blood, cells, scientist, hijack, cell
« Previous | Next »
Similar news on "Scientists solve mystery of how malaria hijacks red blood cells":
- Scientists explain how insulin secreting cells maintain their glucose sensitivity
09-05-2007 · EurekAlert!
Scientists at the leading Swedish medical university Karolinska Institutet have now disclosed the mystery how the insulin-secreting cells maintain an appropriate number of ATP sensing ion channel proteins on their surface. This mechanism, which is described in the latest issue of Cell Metabolism, explains how the human body can keep the blood glucose concentration within the normal range and thereby avoid the development of diabetes.
Similar news · Read more »
- MIT technique reveals inner lives of red blood cells
10-16-2006 · Massachusetts Institute of Technology (MIT)
For the first time, researchers at MIT can see every vibration of a cell membrane, using a technique that could one day allow scientists to create three-dimensional images of the inner workings of living cells.
Similar news · Read more »
- Scientists discover novel way to remove iron from ferritin
11-02-2007 · EurekAlert!
A new study led by Children's Hospital Oakland Research Institute senior scientist, Elizabeth Theil, PhD, is the first to suggest that a small protein or heptapeptide could be used to accelerate the removal of iron from ferritin. The results of this study may help scientists develop new medications that dramatically improve the removal of excess iron in patients diagnosed with blood diseases such as B-Thalassemia (Cooley's anemia) or sickle cell disease.
Similar news · Read more »
- New test predicts blood cancer's sensitivity to experimental cancer drug
01-22-2007 · EurekAlert!
A test developed by Dana-Farber Cancer Institute scientists is the first to identify which malignant blood cells are highly vulnerable to a promising type of experimental drugs that unleash pent-up "cell suicide" factors to destroy the cancer.
Similar news · Read more »
- Researchers discover surprising drug that blocks malaria
01-15-2007 · EurekAlert!
Northwestern University researchers have uncovered how malaria parasites break into red blood cells and how to block the invading parasites with a commonly prescribed high-blood pressure medication. This opens the door for important new drugs to which the parasites are much less likely to become resistant. Malaria is surging worldwide because of drug resistance and the lack of an effective vaccine. Jamaica, which had eradicated the disease for 50 years, recently reported an outbreak.
Similar news · Read more »
- Gene variant linked to moderated symptoms of beta-thalassemia
01-30-2008 · EurekAlert!
Beta-thalassemia is a potentially life-threatening disease that affects red blood cells. As part of the SardiNIA Study of Aging, supported by the National Institute on Aging at the NIH, scientists have found a genetic variant that can explain why some people with beta thalassemia seem to be protected from most dangerous symptoms.
Similar news · Read more »
- MIT-led team ID's malaria-inducing protein
05-21-2007 · Massachusetts Institute of Technology (MIT)
An international team of researchers led by an MIT professor has demonstrated how a key protein in the malaria-inducing parasite Plasmodium falciparum infects red blood cells, causing them to lose their ability to flow through tiny blood vessels.
Similar news · Read more »
- Anticancer drugs might be of benefit to sickle-cell patients
12-06-2007 · EurekAlert!
Although some individuals with the inherited blood disorder sickle cell disease benefit from treatment with hydroxyurea, which increases fetal hemoglobin expression, it does not work for all sickle-cell patients. Now, hope for a new therapy has been provided by the observation that the anticancer drugs lenalidomide and pomalidomide were more effective than hydroxyurea at inducing HbF expression by red blood cells derived in vitro from CD34+ cells from both healthy and sickle-cell individuals.
Similar news · Read more »
- Community Oncology explores pitched debate over anemia-fighting drugs
06-26-2007 · EurekAlert!
The June issue of Elsevier's Community Oncology takes an in-depth look at the charge that ESAs, generally considered vital to cancer patients' quality of life, are overprescribed for profit. Scientists, oncologists and critics of oncologists are in a heated debate now over the use of ESAs, or erythropoiesis-stimulating agents -- drugs that fight anemia by boosting levels of oxygen-carrying red blood cells and the protein hemoglobin.
Similar news · Read more »
- Patient with rare disorder responds to cancer drug
02-13-2008 · EurekAlert!
A rare disorder caused by an excess of two types of immune cells -- the mast cell found in various tissues and its blood-based twin, the basophil -- has successfully been treated with a cancer drug, report scientists from NIAID.
Similar news · Read more »
